Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-11
DOI
10.1038/srep20949
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intraperitoneal Administration of a Novel TAT-BDNF Peptide Ameliorates Cognitive Impairments via Modulating Multiple Pathways in Two Alzheimer’s Rodent Models
- (2015) Yuanyuan Wu et al. Scientific Reports
- Rarity of the Alzheimer Disease–ProtectiveAPPA673T Variant in the United States
- (2015) Li-San Wang et al. JAMA Neurology
- Emerging Targets in Neurodegeneration: New Opportunities for Alzheimer's Disease Treatment?
- (2014) Angela Rampa et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The Peculiar Role of the A2V Mutation in Amyloid-β (Aβ) 1–42 Molecular Assembly
- (2014) Massimo Messa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
- (2014) Janice A. Maloney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Alzheimer Disease Protective Mutation A2T Modulates Kinetic and Thermodynamic Properties of Amyloid-β (Aβ) Aggregation
- (2014) Iryna Benilova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity
- (2014) Yuichi Hashimoto et al. JOURNAL OF NEUROCHEMISTRY
- Neuroprotective Effect of TAT-14-3-3ε Fusion Protein against Cerebral Ischemia/Reperfusion Injury in Rats
- (2014) Yuanjun Zhu et al. PLoS One
- Determination of tissue levels of a neuroprotectant drug: The cell permeable JNK inhibitor peptide
- (2014) Enrico Davoli et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans?
- (2014) Rafael Franco et al. Frontiers in Pharmacology
- Systemic delivery of P42 peptide: a new weapon to fight Huntington’s disease
- (2014) Yoan Arribat et al. Acta Neuropathologica Communications
- Targeted delivery of Neurogenin-2 protein in the treatment for cerebral ischemia-reperfusion injury
- (2013) Bin Deng et al. BIOMATERIALS
- Prolactin Is Not Required for the Development of Severe Chronic Experimental Autoimmune Encephalomyelitis
- (2013) M. Costanza et al. JOURNAL OF IMMUNOLOGY
- Absence of A673T variant in APP gene indicates an alternative protective mechanism contributing to longevity in Chinese individuals
- (2013) Yao-Wen Liu et al. NEUROBIOLOGY OF AGING
- Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity
- (2013) Luisa Diomede et al. NEUROBIOLOGY OF DISEASE
- A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease
- (2013) Vadivel Parthsarathy et al. PLoS One
- HIV-1 Tat Interacts with and Regulates the Localization and Processing of Amyloid Precursor Protein
- (2013) Jiyoung Kim et al. PLoS One
- Oral biodrug delivery using cell-penetrating peptide
- (2012) El-Sayed Khafagy et al. ADVANCED DRUG DELIVERY REVIEWS
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
- (2012) Daniela Galimberti et al. CNS & Neurological Disorders-Drug Targets
- Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
- (2012) Lakshman Puli et al. Journal of Neuroinflammation
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population
- (2012) Mia Kero et al. NEUROBIOLOGY OF AGING
- Intranasal administration of TAT-haFGF14–154 attenuates disease progression in a mouse model of Alzheimer’s disease
- (2012) G. Lou et al. NEUROSCIENCE
- Good gene, bad gene: New APP variant may be both
- (2012) Giuseppe Di Fede et al. PROGRESS IN NEUROBIOLOGY
- Brain Oligomeric β-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice
- (2011) Bibiana DaRocha-Souto et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain
- (2011) Harry D. Samaroo et al. JOURNAL OF NEUROSCIENCE METHODS
- Attenuation of Astrocyte Activation by TAT-Mediated Delivery of a Peptide JNK Inhibitor
- (2011) Woo Hyeun Kang et al. JOURNAL OF NEUROTRAUMA
- Epidemiology of Alzheimer disease
- (2011) Christiane Reitz et al. Nature Reviews Neurology
- Development of a Proteolytically Stable Retro-Inverso Peptide Inhibitor of β-Amyloid Oligomerization as a Potential Novel Treatment for Alzheimer’s Disease
- (2010) Mark Taylor et al. BIOCHEMISTRY
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved side-chain torsion potentials for the Amber ff99SB protein force field
- (2010) Kresten Lindorff-Larsen et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Classification and basic pathology of Alzheimer disease
- (2009) Charles Duyckaerts et al. ACTA NEUROPATHOLOGICA
- An Overview of APP Processing Enzymes and Products
- (2009) Vivian W. Chow et al. NEUROMOLECULAR MEDICINE
- A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis
- (2009) G. Di Fede et al. SCIENCE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now